Edit

Contact Us


    Human Verification

    cropped-gtc_logo_grey_circle_2022

    GTC at ASH 2021

    GTCr-small.png

    Type:

    N/A

    Date (start):

    N/A

    Date (end):

    N/A

    Location:

    T.B.A.

    Booth#:

    Admission Fee: 

    T.B.A.
    Overview:

    GTC is excited to be exhibiting at ASH for the first time and look forward to meeting people in person.  Our booth # 3440 and would like you will stop by and say hello.  

    If you would like to schedule a meeting fill out the form below 

      Human Verification

      We have four abstracts being presented at ASH – here is the schedule below.  

      1. 

      2892 Bone Marrow-Based Biomarkers for Predicting aGVHD Using Targeted RNA Next Generation Sequencing and Machine Learning 

      Program: Oral and Poster Abstracts 
      Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II 
      Hematology Disease Topics & Pathways: 
      Translational Research 

      Sunday, December 12, 2021, 6:00 PM-8:00 PM 

      Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3, Andre H. Goy, MD4*, Spiraggelos Antzoulatos1*, Ivan De Dios, BS1*, Wanlong Ma1*, Sukhdeep Kaur, MD5*, Hyung C. Suh, MD, PhD5*, Michele L. Donato, MD5* and Scott D. Rowley, MD6 

      2. 

      1828 Reliability of Liquid Biopsy and Next Generation Sequencing in Monitoring Residual Disease Post-Hematopoietic Stem Cell Transplant 

      Program: Oral and Poster Abstracts 
      Session: 723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster I 
      Hematology Disease Topics & Pathways: 
      Translational Research 

      Saturday, December 11, 2021, 5:30 PM-7:30 PM 

      Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3, Andre H. Goy, MD, MS4*, Jeffrey Justin Estella, BS, MS1*, Ivan De Dios, BS1*, Wanlong Ma1*, Sukhdeep Kaur, MD5*, Hyung C. Suh, MD, PhD5*, Michele L. Donato, MD5* and Scott D. Rowley, MD6 

      3. 

      2395 Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms 

      Program: Oral and Poster Abstracts 
      Session: 621. Lymphomas: Translational—Molecular and Genetic: Poster II 
      Hematology Disease Topics & Pathways: 
      Clinically Relevant 

      Sunday, December 12, 2021, 6:00 PM-8:00 PM 

      Maher Albitar, MD1*, Hong Zhang, PhD1*, Andre H. Goy, MD, MS2*, Zijun Xu-Monette, PhD3*, Govind Bhagat, M.D.4, Carlo Visco, MD5*, Alexandar Tzankov, MD6*, Xiaosheng Fang3*, Feng Zhu7*, Karen Dybkaer, PhD, MSC8*, April Chiu, MD9*, Wayne Tam, MD, PhD10, Youli Zu, MD, PhD11*, Eric D. Hsi, MD12, F. B. Hagemeister, MD13, Jooryung Huh14*, Maurilio Ponzoni, MD15, Andrés J M Ferreri, MD16, Michael Moller17*, Benjamin M Parsons, DO18, Joannes H.J.M. Van Krieken, PhD, MD19*, Miguel Angel Piris20*, Jane N. Winter, MD21, Yong Li22*, Bing Xu, MD, PhD23* and Ken H. Young24 

      4.  

      3463 Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms 

      Program: Oral and Poster Abstracts 
      Session: 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III 
      Hematology Disease Topics & Pathways: 
      Translational Research 

      Monday, December 13, 2021, 6:00 PM-8:00 PM 

      Maher Albitar, MD1*, Andrew Ip, MD, MSc2, Andre H. Goy, MD3*, Jeffrey Justin Estella, BS, MS1*, Ivan De Dios, BS1*, Wanlong Ma1*, Andrew L. Pecora, MD4*, Jamie Koprivnikar, MD5* and James K McCloskey, MD5